This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia, Acute Lymphoblastic Leukaemia, Myelodysplastic Syndrome, Chronic Myeloid Leukaemia, Chronic Lymphocytic Leukaemia, Acquired Bone Marrow Failure Syndromes or Other Haematological Malignancies; Unrelated HSCT Indicated
and you are
between 16 and 70
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This trial investigates stem cell transplants from partially mismatched donors in patients with blood and bone marrow cancers. The trial will test two kinds of transplants - a full intensity transplant using a high dose of radiotherapy and chemotherapy, and a reduced intensity transplant with lower doses of chemotherapy and radiotherapy. Patients will be entered for the treatment pathway that is most appropriate for their level of health and fitness

Provided treatments

  • Procedure: Reduced intensity haplodentical stem cell transplant
  • Procedure: Myeloablative haploidentical stem cell transplant

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01597219. The sponsor of the trial is University College, London and it is looking for 77 volunteers for the current phase.
Official trial title:
A UK Multicentre Study of Haploidentical Stem Cell Transplantation in Patients With Haematological Malignancies